Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
NCT00842283
This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The researchers believe that pro-angiogenic factors are upregulated in a wide range of dermatologic diseases, including port wine stains, hemangiomas, angiofibromas, Kaposi's sarcoma, angiosarcoma, scars, rosacea, and psoriasis. Select specimens may undergo genetic analysis to investigate underlying molecular pathways associated with dysregulated angiogenesis in cutaneous disease. Biospecimens, either previously obtained or newly collected from dermatologic conditions, will be analyzed for angiogenic markers.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Dermatologic Diseases
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 16 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of California, Irvine
- Last updated on ClinicalTrials.gov
- April 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 2
- Beckman Laser Institute and Medical Clinic · Irvine, CA
- Dermatology Clinic at Gavin Herbert Eye Institute · Irvine, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.